Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

European approval for NovoRapid in pregnant women with diabetes

Aug. 2, 2006

Phase III PolyHeme study completes enrollment

Aug. 2, 2006

Phyton Biotech to develop Iplex manufacturing process

Aug. 2, 2006

Caspase inhibition with z-VAD-FMK attenuates immediate islet mass loss in transplanted mice

Aug. 2, 2006

Recent patents reveal novel compounds with possible activity in metabolic disorders

Aug. 1, 2006

MK-0431A for type 2 diabetes accepted for review

Aug. 1, 2006

Zydus Cadila cleared for phase I studies of ZYH-2 for diabetes

Aug. 1, 2006

duetact approved for type 2 diabetes

July 31, 2006

Genotropin approved in Japan for severe adult growth hormone deficiency

July 31, 2006

New agents for diabetes imparted in recent patent literature

July 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...